CB 30900

Known as: CB-30900, CB30900 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
The inhibition of thymidylate synthase (TS) as a drug development target has received much attention in recent years, and several… (More)
Is this relevant?
1996
1996
CB30900 is a novel, potent thymidylate synthase inhibitor which can not be polyglutamated and may be active in cancers expressing… (More)
Is this relevant?